Another thing to note: the company producing the product (in this case the vaccines) applies for an Emergency Use Authorization - not the other way around. The FDA is not proactively reaching out to companies asking them to submit EUAs.
If a company is granted an EUA, that does not give them the power to suspend their normal trial processes and automatically apply for approval.